Clinical Trial Update: Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss [Phase 2]

View source ↗

Summary

Update on a Phase 2 dose-ranging trial evaluating the topical NEOSH101 for male pattern hair loss (androgenetic alopecia) by Neosil, Inc.; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• NEOSH101

Snippet

Sponsor: Neosil, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: UNKNOWN